118th Congress · HOUSE BILLBILL

H.R. 2500Protecting Americans from Unsafe Drugs Act of 2023

To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.

Health
Introduced Apr 6, 2023
Last action Apr 14, 2023
Pipeline · Bill → Law
Step 1
Introduced
Apr 6, 2023
Step 2
Referred
Apr 14, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)

Provisions · 2 sectionsIntroduced in House
Timeline · 3 actions
Apr 14, 2023
Referred to the Subcommittee on Health.
Apr 6, 2023
Introduced in House
Apr 6, 2023
Referred to the House Committee on Energy and Commerce.